Generate Biomedicines

Company profile

About Generate Biomedicines

Generate Biomedicines is a biotechnology company at the forefront of applying generative artificial intelligence to therapeutic protein design and drug discovery. The company has developed a proprietary generative biology platform that uses machine learning to create novel protein therapeutics from scratch, rather than modifying existing proteins. This approach enables the design of proteins with specific therapeutic properties tailored to address unmet medical needs. Generate Biomedicines' technology platform combines deep learning, structural biology, and computational protein design to generate and optimize therapeutic candidates across multiple modalities including antibodies, peptides, and other protein-based drugs. The company's mission is to expand the druggable proteome and accelerate the development of breakthrough medicines. By leveraging generative AI, Generate Biomedicines aims to design proteins that are difficult or impossible to create using traditional methods, potentially unlocking new therapeutic opportunities across various disease areas. The company serves the biopharmaceutical industry and is developing its own pipeline of therapeutic candidates while also partnering with pharmaceutical companies to apply its platform to their drug discovery programs.

Company description · Generate Biomedicines official website

Mission. Democratizing biotherapeutics and pioneering generative biology to create breakthrough medicines.